Literature DB >> 17957223

Expression and function of CB1 receptor in the rat striatum: localization and effects on D1 and D2 dopamine receptor-mediated motor behaviors.

Ana Belén Martín1, Emilio Fernandez-Espejo, Belén Ferrer, Miguel Angel Gorriti, Ainhoa Bilbao, Miguel Navarro, Fernando Rodriguez de Fonseca, Rosario Moratalla.   

Abstract

Cannabinoid CB1 receptors are densely expressed on striatal projection neurons expressing dopamine D1 or D2 receptors. However, the specific neuronal distribution of CB1 receptors within the striatum is not known. Previous research has established that the endocannabinoid system controls facilitation of behavior by dopamine D2 receptors, but it is not clear if endocannabinoids also modulate D1 receptor-mediated motor behavior. In the present study, we show that cannabinoid CB1 receptor mRNA is present in striatonigral neurons expressing substance P and dopamine D1 receptors, as well as in striatopallidal neurons expressing enkephalin and dopamine D2 receptors. We explored the functional relevance of the interaction between dopamine D1 and D2 receptors and cannabinoid CB1 receptors with behavioral pharmacology experiments. Potentiation of endogenous cannabinoid signaling by the uptake blocker AM404 blocked dopamine D1 receptor-mediated grooming and D2 receptor-mediated oral stereotypies. In addition, contralateral turning induced by unilateral intrastriatal infusion of D1 receptor agonists is counteracted by AM404 and potentiated by the cannabinoid antagonist SR141716A. These results indicate that the endocannabinoid system negatively modulates D1 receptor-mediated behaviors in addition to its previously described effect on dopamine D2 receptor-mediated behaviors. The effect of AM404 on grooming behavior was absent in dopamine D1 receptor knockout mice, demonstrating its dependence on D1 receptors. This study indicates that the endocannabinoid system is a relevant negative modulator of both dopamine D1 and D2 receptor-mediated behaviors, a finding that may contribute to our understanding of basal ganglia motor disorders.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17957223     DOI: 10.1038/sj.npp.1301558

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  55 in total

Review 1.  Adenosine-cannabinoid receptor interactions. Implications for striatal function.

Authors:  Sergi Ferré; Carme Lluís; Zuzana Justinova; César Quiroz; Marco Orru; Gemma Navarro; Enric I Canela; Rafael Franco; Steven R Goldberg
Journal:  Br J Pharmacol       Date:  2010-06       Impact factor: 8.739

2.  Mechanism for differential recruitment of orbitostriatal transmission during actions and outcomes following chronic alcohol exposure.

Authors:  Rafael Renteria; Christian Cazares; Emily T Baltz; Drew C Schreiner; Ege A Yalcinbas; Thomas Steinkellner; Thomas S Hnasko; Christina M Gremel
Journal:  Elife       Date:  2021-03-17       Impact factor: 8.140

3.  Cannabinoid receptors CB1 and CB2 form functional heteromers in brain.

Authors:  Lucía Callén; Estefanía Moreno; Pedro Barroso-Chinea; David Moreno-Delgado; Antoni Cortés; Josefa Mallol; Vicent Casadó; José Luis Lanciego; Rafael Franco; Carmen Lluis; Enric I Canela; Peter J McCormick
Journal:  J Biol Chem       Date:  2012-04-24       Impact factor: 5.157

Review 4.  Looking for the role of cannabinoid receptor heteromers in striatal function.

Authors:  Sergi Ferré; Steven R Goldberg; Carme Lluis; Rafael Franco
Journal:  Neuropharmacology       Date:  2008-07-19       Impact factor: 5.250

5.  Altered brain cannabinoid 1 receptor mRNA expression across postnatal development in the MAM model of schizophrenia.

Authors:  Felipe V Gomes; Jessica R Edelson; David W Volk; Anthony A Grace
Journal:  Schizophr Res       Date:  2018-04-26       Impact factor: 4.939

6.  The endocannabinoid 2-arachidonoylglycerol mediates D1 and D2 receptor cooperative enhancement of rat nucleus accumbens core neuron firing.

Authors:  T Seif; A Makriyannis; G Kunos; A Bonci; F W Hopf
Journal:  Neuroscience       Date:  2011-07-27       Impact factor: 3.590

Review 7.  Mechanisms underlying the onset and expression of levodopa-induced dyskinesia and their pharmacological manipulation.

Authors:  Mahmoud M Iravani; Peter Jenner
Journal:  J Neural Transm (Vienna)       Date:  2011-09-01       Impact factor: 3.575

8.  Genome-wide Analysis of RARβ Transcriptional Targets in Mouse Striatum Links Retinoic Acid Signaling with Huntington's Disease and Other Neurodegenerative Disorders.

Authors:  Anna Niewiadomska-Cimicka; Agnieszka Krzyżosiak; Tao Ye; Anna Podleśny-Drabiniok; Doulaye Dembélé; Pascal Dollé; Wojciech Krężel
Journal:  Mol Neurobiol       Date:  2016-07-12       Impact factor: 5.590

9.  Functional characterization of G-protein-coupled receptors: a bioinformatics approach.

Authors:  L Tovo-Rodrigues; A Roux; M H Hutz; L A Rohde; A S Woods
Journal:  Neuroscience       Date:  2014-07-02       Impact factor: 3.590

10.  Selective vulnerability in striosomes and in the nigrostriatal dopaminergic pathway after methamphetamine administration : early loss of TH in striosomes after methamphetamine.

Authors:  Noelia Granado; Sara Ares-Santos; Esther O'Shea; Carlos Vicario-Abejón; M Isabel Colado; Rosario Moratalla
Journal:  Neurotox Res       Date:  2009-09-04       Impact factor: 3.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.